Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 43 CNY -4.04%
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acrobiosystems Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
Other Long-Term Assets
ÂĄ103.7m
CAGR 3-Years
95%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Long-Term Assets
ÂĄ304.3m
CAGR 3-Years
-29%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Other Long-Term Assets
ÂĄ8.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Long-Term Assets
ÂĄ405.6m
CAGR 3-Years
39%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Long-Term Assets
ÂĄ132.9m
CAGR 3-Years
-37%
CAGR 5-Years
-12%
CAGR 10-Years
9%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Long-Term Assets
ÂĄ1.2B
CAGR 3-Years
24%
CAGR 5-Years
38%
CAGR 10-Years
32%
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
48.56 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
103.7m CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's Other Long-Term Assets amounts to 103.7m CNY.

What is Acrobiosystems Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
74%

Over the last year, the Other Long-Term Assets growth was 14%. The average annual Other Long-Term Assets growth rates for Acrobiosystems Co Ltd have been 95% over the past three years , 74% over the past five years .

Back to Top